Similarly, serum levels of IL-6, a traditional marker of systemic inflammation, were found to be higher in IBS patients compared to controls, but only in one patient subtype (diarrhea predominant), indicating inter-phenotypic variations in the levels of inflammation [115]. Here, IL6 is linked to irritable bowel syndrome.